|Name||STELLA PHARMA CORPORATION|
|Established||June 1, 2007|
|Main office||3-2-7 Korai-bashi, Chuo-ku, Osaka, Osaka Prefecture 541-0043|
|Description of business||Research, development, manufacturing, and sales of pharmaceuticals and medical devices|
|Capital||1.9 billion yen|
|Shareholders||Stella Chemifa, Innovation Network Corporation of Japan, Sumitomo Heavy Industries, Ltd.|
|Number of employees||40 (as of March 2019)|
|Laboratory||Sakai R&D Center, Tokyo Office|
|June 2007||Stella Pharma founded|
|July 2008||First-class marketing license for pharmaceuticals obtained (Osaka Prefecture)|
|December 2013||First-class marketing license for medical devices obtained (Osaka Prefecture)|
|January 2014||The Sanpo and Nakamozu laboratories merged with the Sakai R&D Center|
- To faithfully uphold the Act on Pharmaceuticals and Medical and Devices and related laws and regulations including GMP, GCP and GQP while developing new products.
- To establish an organization that is suited for the pharmaceutical and medical device industry and strives for continuous improvement.
- To enhance our mission and moral values as a provider of pharmaceutical products and medical devices through education and practice.